Where to buy telisotuzumab-EMRELIS in China and instructions for purchasing the drug through regular channels

Telisotuzumab-EMRELIS is not yet officially launched in China, so domestic patients are temporarily unable to purchase the drug directly through hospitals or pharmacies. This means that the purchase and use of this drug cannot be provided in the domestic conventional medical system, including public hospitals and commercial pharmacies. For patients who wish to use the drug, they first need to clarify their treatment indications and whether their condition complies with overseas clinical guidelines to ensure the safety and rationality of the drug.

Overseas markets are currently the main way to obtain terituzumab. The drug has been approved for marketing in some countries, and patients can obtain it through international medical cooperation, cross-border hospitals or regular overseas pharmacy channels. The price of overseas original drugs is relatively high, with each box or tube selling for about 45,000 yuan. Since it is an original drug, there is no imitation version on the market yet, so the price is difficult to drop significantly. At the same time, the drug ingredients and efficacy are relatively guaranteed.

When purchasing drugs overseas, it is particularly important to choose formal channels. Patients should purchase drugs through legally qualified international pharmacies, cross-border medical platforms or regulated hospital cooperation projects to ensure that the source of the drugs is reliable and comes with original manufacturer certificates and cold chain transportation guarantees. Drugs from informal channels have risks of unknown ingredients, improper storage conditions or counterfeit drugs, which pose a serious threat to patient safety and must be strictly avoided.

In addition, territuzumab is an intravenous drug and must be used under the guidance of professional medical staff to ensure that the dosage, administration speed and monitoring measures comply with specifications. Patients should fully communicate with their doctors before purchasing drugs, including assessing potential adverse reactions, tolerance and treatment schedule. At the same time, considering the high price of drugs, family financial ability is also an important factor in drug purchasing decisions. Generally speaking, domestic patients can currently only obtain EMRELIS through legal overseas channels and must strictly follow the guidance of medical professionals.

Keyword tag:

Telituzumab, Telisotuzumab, EMRELIS, c-Met, non-small cell lung cancer, NSCLC, domestic purchase, drug purchase channels, original drug, price, generic drug, intravenous injection

References:https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-telisotuzumab-vedotin-tllv-for-nsclc-high-c-met-protein-overexpression